Cancer Prevention and Research Institute of Texas
211 East 7th Street
Suite 300
Austin
Texas
78701
United States
Tel: 512-463-3190
Fax: 512-475-2563
33 articles about Cancer Prevention and Research Institute of Texas
-
Gradalis Awarded $9.9 Million Grant From the Cancer Prevention and Research Institute of Texas
11/16/2023
Gradalis, Inc. announced that it has been awarded a $9.9 million Product Development Research grant from the Cancer Prevention and Research Institute of Texas.
-
OncoResponse Awarded $13 Million in Funding from CPRIT and Raises $14 Million in Added Funds from Investors to Advance Cancer Immunotherapy
5/18/2023
OncoResponse today announced it has been awarded a $13 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT).
-
Plus Therapeutics Executes $17.6 Million Award Contract with Cancer Prevention & Research Institute of Texas
9/22/2022
Plus Therapeutics, Inc. today announced that it has finalized and signed a grant contract with the Cancer Prevention & Research Institute of Texas (CPRIT) for its previously announced $17.6 million Product Development Research funding award.
-
PanTher Therapeutics Awarded $14.2M from CPRIT to Advance Targeted, Localized and Sustained Cancer Treatment
8/22/2022
PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage oncology company developing next-generation targeted therapies for solid tumors, received a $14.2 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT).
-
OncoNano Announces $18.4 Million Equity Investment by the Cancer Prevention and Research Institute of Texas
10/25/2021
OncoNano Medicine, Inc. today announced that the Cancer Prevention and Research Institute of Texas (CPRIT) will convert $18.4 million in grant award funding into an equity investment in OncoNano.
-
Medicenna Receives US $1.9 Million Non-Dilutive Grant Payment
7/9/2019
Medicenna Therapeutics Corp., a clinical stage immuno-oncology company, announced that it has received US$1,915,264 from the Cancer Prevention and Research Institute of Texas.
-
$50 million awarded by CPRIT to MD Anderson and its projects
8/24/2018
The University of Texas MD Anderson Cancer Center today was awarded $30 million to support research, core facilities, recruitment and prevention efforts from the Cancer Prevention and Research Institute of Texas (CPRIT).
-
ESSA Pharma Receives US$1.2 Million Grant Payment From Cancer Prevention and Research Institute of Texas
4/5/2017
-
ESSA Pharma Receives US$4.0 Million Grant Payment From Cancer Prevention and Research Institute of Texas
1/30/2017
-
Ruga Corporation Announces Move To Houston With $20 Million Grant From Cancer Prevention and Research Institute of Texas And Name Change To Aravive Biologics
11/21/2016
-
Cancer Prevention and Research Institute of Texas Awards Pulmotect $7.1 Million to Develop Novel Immune System Stimulant
5/9/2012
-
Asuragen, Inc. Awarded $6.8 Million Commercialization Award from the Cancer Prevention and Research Institute of Texas
3/30/2012
-
Cancer Prevention and Research Institute of Texas Combats Rising Economic and Human Impact of Cancer
1/19/2012
-
Cancer Prevention and Research Institute of Texas Enters Agreement with Roche Aimed at Advancing Texas’ Fight Against Cancer
7/7/2011
-
Bellicum Pharmaceuticals, Inc. Awarded $5.7 Million by the Cancer Prevention and Research Institute of Texas
3/25/2011
-
Cancer Prevention and Research Institute of Texas Starts Second Year by Adding More Than $40 Million in Grant Awards to Cancer Research Portfolio
11/1/2010
-
Top Cancer Experts to Convene in Austin to Celebrate First-Year Achievements by Cancer Prevention and Research Institute of Texas
10/26/2010
-
Rules-Based Medicine, Inc. Awarded Funding from the Cancer Prevention and Research Institute of Texas
7/6/2010
-
Apollo Endosurgery, Inc. Recommended for $5 Million Commercialization Award From the Cancer Prevention and Research Institute of Texas
6/23/2010
-
Mirna Therapeutics, Inc. Recommended for $10 Million Commercialization Award from the Cancer Prevention and Research Institute of Texas
6/21/2010